Given Imaging Ltd. (NASDAQ:GIVN)

CAPS Rating: 4 out of 5

The Company develops, manufactures and markets innovative diagnostic products for the visualization and detection of disorders of the gastrointestinal tract.

Results 1 - 20 of 24 : 1 2 Next »

Recs

0
Member Avatar chandles (< 20) Submitted: 7/6/2013 8:51:51 AM : Outperform Start Price: $13.94 GIVN Score: +101.32

Why will this stock outperform the S&P 500?

Recs

0
Member Avatar bentjeans (< 20) Submitted: 1/24/2011 7:06:35 PM : Outperform Start Price: $17.74 GIVN Score: +24.24

GIVN has just been approved for an entirely new line of business with PH monitoring. Plus it is near the low of it's 2 year price cycle. As battery life improves the utility of the company's devices continues to increase. Physicians around the world are gradually being exposed to GIVN products.

Recs

0
Member Avatar mellis2211 (< 20) Submitted: 8/14/2010 5:17:26 PM : Outperform Start Price: $13.50 GIVN Score: +51.09

An Israeli start-up leading the way in bio-imagery using their inventive PillCams.

Recs

0
Member Avatar Esqangel (< 20) Submitted: 5/12/2010 9:46:21 PM : Outperform Start Price: $14.82 GIVN Score: +18.95

Given's products are cutting edge

Recs

0
Member Avatar mdmardim (< 20) Submitted: 3/4/2010 9:16:55 PM : Outperform Start Price: $19.75 GIVN Score: -12.61

Finds what the scope can't find.

Recs

0
Member Avatar yeraz (66.72) Submitted: 10/11/2008 9:24:44 PM : Outperform Start Price: $7.54 GIVN Score: +195.37

Non-invasive medical imaging.

Recs

0
Member Avatar monikasfantasy (< 20) Submitted: 5/2/2008 12:24:06 PM : Outperform Start Price: $14.98 GIVN Score: +57.31

GOTTA LOVE THOSE ISREALIES

Recs

0
Member Avatar Miss57 (43.78) Submitted: 3/27/2008 8:04:17 PM : Underperform Start Price: $16.19 GIVN Score: -39.85

Too much activity with other companies. Isralian have problem with longivity

Recs

0
Member Avatar CORLEY11 (< 20) Submitted: 2/21/2008 6:28:59 PM : Outperform Start Price: $15.21 GIVN Score: +53.13

AS SOON AS THEY GET APPROVAL FROM THE FDA THIS STOCK SHOULD PERFORM WELL

Recs

0
Member Avatar SnowWhite418 (< 20) Submitted: 2/9/2008 4:21:16 PM : Outperform Start Price: $14.99 GIVN Score: +54.07

Accelerated growth potential with FDA approval of new products.

Recs

0
Member Avatar yisroel18 (64.81) Submitted: 11/1/2007 3:12:14 PM : Outperform Start Price: $25.38 GIVN Score: -10.02

the need for this will be on the rise as the baby boomers get of age people are getting sicker

Recs

0
Member Avatar DoctorsL (< 20) Submitted: 7/8/2007 2:09:04 PM : Outperform Start Price: $28.25 GIVN Score: -21.97

Esophogeal cancer is, unfortunately, on the rise. The imaging product holds promise. It will take a while to catch on, but it can be viewed as a significant gain for the health sector.

Recs

0
Member Avatar 1Hippydippy (< 20) Submitted: 7/4/2007 11:53:02 PM : Outperform Start Price: $28.96 GIVN Score: -25.21

no invasive ways to check GI, with the aging population what could be better

Recs

0
Member Avatar changcellor (< 20) Submitted: 7/4/2007 4:37:06 AM : Outperform Start Price: $28.96 GIVN Score: -25.21

what i would want if i am having an intestine check

Recs

1
Member Avatar aubree09876 (< 20) Submitted: 6/8/2007 4:50:24 PM : Outperform Start Price: $23.04 GIVN Score: -0.45

This company is poised to make big profits. The new CEO from Kodak is well-known for his ability to make a company grow, and it is in the next few months that the appointment will pay off.

Recs

0
Member Avatar kitfine (< 20) Submitted: 6/8/2007 11:33:53 AM : Outperform Start Price: $23.21 GIVN Score: -2.41

it's ready to turn a profit

Recs

0
Member Avatar ztur2218 (< 20) Submitted: 3/12/2007 2:30:54 PM : Outperform Start Price: $19.18 GIVN Score: +16.01

great products great company

Recs

1
Member Avatar tstokesbme (86.09) Submitted: 3/4/2007 1:49:29 PM : Outperform Start Price: $18.37 GIVN Score: +19.77

My stepmom works for this company. I've also interacted with some of the managers about a technology project for an image processing class. I think the story is solid. I need to find out more about the patent protection before I buy.

Recs

0
Member Avatar kokit74 (< 20) Submitted: 2/21/2007 1:11:28 AM : Underperform Start Price: $20.37 GIVN Score: -11.30

It's P/E is VERY high considering it's expected growth

Recs

0
Member Avatar shaiet (< 20) Submitted: 12/25/2006 3:04:52 PM : Outperform Start Price: $18.63 GIVN Score: +20.41

Great technolgy of a small canera that travel your insides and map tumors. Already approved by FDA, only competition is Olympus.

Results 1 - 20 of 24 : 1 2 Next »

Featured Broker Partners


Advertisement